Cite
MLA Citation
K. Nishikawa et al.. “2329 A randomized phase III study of S-1 alone versus S-1 plus immunomodulator lentinan for unresectable or recurrent gastric cancer (JFMC36–0701).” European journal of cancer, vol. 51, n.d., pp. S442–. http://access.bl.uk/ark:/81055/vdc_100030628218.0x000037